Overview
Rachel Rosenblum is an Oncologist in Middletown, New Jersey. Dr. Rosenblum has been practicing medicine for over 10 years is highly rated in 7 conditions, according to our data. Her top areas of expertise are Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Pleuropulmonary Blastoma. Dr. Rosenblum is currently accepting new patients.
Her clinical research consists of co-authoring 4 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Graduate Year
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
480 Red Hill Rd, Middletown, NJ 07748
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
David H. Koch Center For Cancer Care At Memorial Sloan Kettering Cancer Center
Steven Horwitz is a Hematologist and an Oncologist in New York, New York. Dr. Horwitz is highly rated in 26 conditions, according to our data. His top areas of expertise are Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, and Bone Marrow Aspiration. Dr. Horwitz is currently accepting new patients.
Rockefeller Outpatient Pavilion
William Tap is an Oncologist in New York, New York. Dr. Tap is highly rated in 32 conditions, according to our data. His top areas of expertise are Adult Soft Tissue Sarcoma, Gastrointestinal Stromal Tumor, Angiosarcoma, Tissue Biopsy, and Liver Embolization. Dr. Tap is currently accepting new patients.
Rockefeller Outpatient Pavilion
Sandra D'angelo is an Oncologist in New York, New York. Dr. D'angelo is highly rated in 33 conditions, according to our data. Her top areas of expertise are Synovial Sarcoma, Adult Soft Tissue Sarcoma, Merkel Cell Carcinoma, Liposarcoma, and Liver Embolization. Dr. D'angelo is currently accepting new patients.
Frequently Asked Questions about Dr. Rachel Rosenblum
How do I make an appointment with Dr. Rachel Rosenblum?
You can book an appointment with Dr. Rachel Rosenblum by calling their office at 732-630-6420. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Rachel Rosenblum a top-rated expert for Small Cell Lung Cancer (SCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Rachel Rosenblum is classified as an Advanced expert for Small Cell Lung Cancer (SCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Rachel Rosenblum specialize in?
While Dr. Rachel Rosenblum is a Oncology, they have specific expertise in Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, and ALK-Positive Non-Small Cell Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Rachel Rosenblum participate in research or clinical trials?
Yes. Dr. Rachel Rosenblum has published 4 articles and abstracts on conditions like Small Cell Lung Cancer (SCLC). You can view a list of Dr. Rachel Rosenblum's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Rachel Rosenblum accept my insurance?
Dr. Rachel Rosenblum accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 732-630-6420 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- ALK-Positive Non-Small Cell Lung CancerDr. Rosenblum isAdvanced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Lung CancerDr. Rosenblum isAdvanced. Learn about Lung Cancer.
- MesotheliomaDr. Rosenblum isAdvanced. Learn about Mesothelioma.
- Metastatic Pleural TumorDr. Rosenblum isAdvanced. Learn about Metastatic Pleural Tumor.
- Pleuropulmonary BlastomaDr. Rosenblum isAdvanced. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Rosenblum isAdvanced. Learn about Small Cell Lung Cancer (SCLC).
- Experienced
- EGFR Positive Lung CancerDr. Rosenblum isExperienced. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Rosenblum isExperienced. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Rosenblum isExperienced. Learn about Lung Adenocarcinoma.
- Lynch SyndromeDr. Rosenblum isExperienced. Learn about Lynch Syndrome.
- Metastatic Brain TumorDr. Rosenblum isExperienced. Learn about Metastatic Brain Tumor.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Rosenblum isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).